Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

About: Oclacitinib

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Oclacitinib (brand name Apoquel) is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. It inhibits signal transduction when the JAK is activated and thus helps downregulate expression of inflammatory cytokines. While oclacitinib is effective, its long-term safety is currently unknown. Oclacitinib was approved by the FDA in 2013.

Property Value
dbo:abstract
  • Oclacitinib (brand name Apoquel) is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. It inhibits signal transduction when the JAK is activated and thus helps downregulate expression of inflammatory cytokines. While oclacitinib is effective, its long-term safety is currently unknown. Oclacitinib was approved by the FDA in 2013. (en)
dbo:alternativeName
  • Apoquel (en)
dbo:bioavailability
  • 89.000000 (xsd:float)
dbo:casNumber
  • 1208319-26-9
dbo:chEMBL
  • 2103874
dbo:class
dbo:fdaUniiCode
  • 99GS5XTB51
dbo:kegg
  • D10141
dbo:pubchem
  • 44631938
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 53282326 (xsd:integer)
dbo:wikiPageLength
  • 15821 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1120064630 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • D11 (en)
dbp:atcSuffix
  • AH90 (en)
dbp:atcvet
  • yes (en)
dbp:bioavailability
  • 89.0 (dbd:perCent)
dbp:c
  • 15 (xsd:integer)
dbp:casNumber
  • 1208319 (xsd:integer)
dbp:chembl
  • 2103874 (xsd:integer)
dbp:chemspiderid
  • 28528036 (xsd:integer)
dbp:class
dbp:eliminationHalfLife
  • -18720.0 (dbd:second)
dbp:excretion
  • Mostly liver (en)
dbp:h
  • 23 (xsd:integer)
dbp:image
  • Apoquel bottle.jpg (en)
dbp:iupacName
  • N-Methyl{trans-4-[methylamino]cyclohexyl}methanesulfonamide (en)
dbp:kegg
  • D10141 (en)
dbp:legalStatus
  • Rx-only (en)
dbp:metabolism
dbp:n
  • 5 (xsd:integer)
dbp:o
  • 2 (xsd:integer)
dbp:proteinBound
  • 66.300000 (xsd:double)
dbp:pubchem
  • 44631938 (xsd:integer)
dbp:routesOfAdministration
  • By mouth (en)
dbp:s
  • 1 (xsd:integer)
dbp:smiles
  • CNSC[C@@H]1CC[C@H]Nc2[nH]cnc3nccc23 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • HJWLJNBZVZDLAQ-HAQNSBGRSA-N (en)
dbp:synonyms
  • PF-03394197 (en)
dbp:tradename
  • Apoquel (en)
dbp:unii
  • 99 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Oclacitinib (brand name Apoquel) is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. It inhibits signal transduction when the JAK is activated and thus helps downregulate expression of inflammatory cytokines. While oclacitinib is effective, its long-term safety is currently unknown. Oclacitinib was approved by the FDA in 2013. (en)
rdfs:label
  • Oclacitinib (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License